Related Experiment Videos
Brugada
1Division of Cardiology, Department of Medicine, University of Miami School of Medicine, Miami, Fla., USA.
Summary
Brugada syndrome, a genetic heart condition, can cause syncope during physical activity. Early diagnosis and implantable cardioverter-defibrillator (ICD) therapy are crucial for preventing sudden cardiac death (SCD).
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Brugada syndrome is a genetic disorder affecting cardiac ion channels.
- It is characterized by specific ECG abnormalities (RBBB, ST-segment elevation in V1-V3).
- Symptoms like palpitations and syncope typically occur at rest but can manifest during physical activity.
Observation:
- A case is presented where Brugada syndrome symptoms occurred exclusively during physical exertion.
- Electrophysiology study (EPS) confirmed the diagnosis.
- An implantable cardioverter-defibrillator (ICD) was successfully implanted.
Findings:
- Brugada syndrome is genetically determined, linked to cardiac ion channel mutations.
- Signal averaging can identify individuals at high risk for sudden cardiac death (SCD).
- EPS is essential for diagnosing Brugada syndrome and identifying SCD risk.
Implications:
- Brugada syndrome highlights the risk of SCD in affected patients.
- ICD implantation is the sole proven therapy to prevent SCD in Brugada syndrome.
- Identifying high-risk individuals through signal averaging and EPS is critical for timely intervention.